Source comparison
Ipamorelin Sleep Protocol: Comparison of Dosing Strategies
30–60 min before sleep Synchronises with natural nocturnal GH pulse (60–90 min post-sleep onset) 30–45% increase in Stage 3/4 duration within 10 days Minimal. Occasional transient flushing at doses >250mcg Optimal timing for sleep architecture improvement; thi
This comparison does not assign a generated winner or score.
- 30–60 min before sleep
- Synchronises with natural nocturnal GH pulse (60–90 min post-sleep onset)
- 30–45% increase in Stage 3/4 duration within 10 days
- Minimal. Occasional transient flushing at doses >250mcg
- Optimal timing for sleep architecture improvement; this is the gold-standard protocol
- 90–120 min before sleep
- Partial alignment. GH peak occurs during sleep onset rather than deep sleep phase
- 15–25% increase; less pronounced than optimal window
- Same as above
- Suboptimal but functional if scheduling constraints prevent later dosing
- Morning or midday administration
- Zero alignment. GH pulse occurs during wakefulness, does not influence sleep architecture
- <5% increase, often undetectable
- Higher cortisol response; may interfere with natural circadian GH rhythm
- Ineffective for sleep quality; suitable only for other research endpoints (e.g., recovery, body composition)
- Split-dose protocol (AM + PM)
- Disrupts natural pulsatile rhythm; flattens GH curve
- Inconsistent; often worse than single PM dose
- Elevated prolactin and cortisol from sustained GH elevation
- Not recommended for sleep optimisation; increases side effect risk without benefit